Adisseo has appointed Li Bo as Chairman and Chief Executive Officer as it targets further growth across methionine, specialty products, and vitamins. Mr Li was elected Chairman of the Board on September 11 and will succeed Hao Zhigang as CEO on November 1. He will oversee the company’s strategy and Executive Leadership Team.
His priorities include reinforcing Adisseo’s position in methionine, developing specialty nutrition as a key growth segment, and transforming its vitamin operations.
“I am honored to join Adisseo at this important moment in its development,” said Mr Li. “We will continue investing in innovation, people and operational excellence.”
Outgoing CEO Hao said the company had built a strong platform, supported by its teams and assets.
